neuro/cognition · applied
Reference snapshot
This snapshot describes the state of the editorial record, not a diagnosis or a recommendation to intervene.
Claim ledger
These are declared editorial claim-to-source mappings. A mapping does not establish independent verification of the claim or its support. Citation controls open the corresponding source record.
Signal
Sleep, exercise, and defined attention-training tasks have a more defensible evidence base than generalized intelligence-enhancement claims.
Boundary
Transfer beyond the trained task depends on protocol fidelity, comparator quality, population, and objective follow-up.
Not established
A consumer score, subjective alertness change, or narrow task gain does not establish broad cognitive enhancement or a medical effect.
Mechanism map (working model)
A simplified causal map for orientation; it is not a diagnosis or a deterministic prediction.
Input or intervention
Cognition and Performance Systems
Biological pathway
neuro/cognition pathway shaped by dose, context, and individual response
Measurable signal
Cognitive performance practices combine attention training, neurofeedback, sleep, exercise, and device-mediated stimulation; transfer beyond the trained task remains the central question.
Boundary
Anxiety, sleep disruption, overtraining, and false confidence from task-specific gains.
Research appraisal checklist
Evidence to prioritize
Human comparative studies, validated measurement, realistic adherence, dose or context reporting, and evidence that the effect transfers beyond the training setting.
Outcome anchor
Require transfer to real-world function, not only engagement, immersion, stimulation sensation, or an algorithmic performance score.
Main uncertainty
The main uncertainty is whether the observed signal is causal, durable, and relevant outside the exact study context.
What would change the conclusion
Upgrade confidence only when independent studies reproduce the result and make harms, adherence, and durability visible.
Minimum diligence questions
- Are the intervention, dose or exposure, comparator, population, and measurement conditions clearly defined?
- Do the outcomes matter outside the experiment, and are missing data, adverse events, and conflicts visible?
- Can the result be reproduced independently, and does it justify the level of risk being discussed?
Application and translation pathway
Current application boundary
Cognition and Performance Systems is currently best understood as a applied neuro/cognition domain; practical use should stay within the evidence and safety boundary described in this dossier.
Research and applied uses
- Measurement and hypothesis testing in neuro/cognition
- Protocol design with defined outcomes and context
- Low-risk applied experimentation with reversible changes
A staged map for separating an interesting mechanism from a reproducible, useful, and responsibly deployable application.
Question
Define the population, intervention, comparator, and outcome before interpreting a signal.
Signal
Check measurement validity, adherence, confounding, and whether the result repeats.
Function
Ask whether the change improves meaningful daily function or clinical outcomes.
Boundary
Preserve normal functioning and stop when symptoms or risk increase.
Research and clinical readout
Research status
Cognitive performance research is strongest for sleep, exercise, attention training, and indication-specific neurofeedback or photobiomodulation; broad transfer to general intelligence remains uncertain.
Signal confidence
Grade C (Moderate for foundational behaviors and narrow tasks; lower for generalized enhancement claims and consumer device scores.)
Key question
Do gains transfer to untrained tasks and everyday function after novelty and practice effects are controlled?
Clinical perspective
Start with sleep, exercise, mood, medication review, and a clear functional target before adding stimulation or supplements.
Clinical uncertainty
How much consumer neurofeedback or photobiomodulation can be responsibly used outside defined clinical indications.
Community patterns
Users often notice short-term focus or alertness changes before objective transfer is demonstrated.
Common community failure mode
Treating a trained reaction-time or dashboard score as proof of broad cognitive improvement.
Where this is heading
Better preregistered transfer tests and passive-to-active outcome pairing should clarify which tools improve function outside the training environment.
What to track next
Cognitive performance practices combine attention training, neurofeedback, sleep, exercise, and device-mediated stimulation; transfer beyond the trained task remains the central question.
Protocol and safety scaffold
Risk gate: Start with low-risk foundations and preserve normal functioning while testing one variable.
Baseline first
- Define one meaningful outcome and a comparison window before changing the protocol.
- Record relevant symptoms, sleep, workload, medications, and confounders at baseline.
Implementation pattern
- Change one variable at a time and use the smallest meaningful intervention.
- Predefine review, washout, and escalation criteria before looking at results.
Monitor
- Track the target outcome alongside symptoms, function, and adherence.
- Check data quality and context before treating a change as a signal.
Pause or stop rules
- Pause for new or worsening symptoms, reduced normal function, or a meaningful safety concern.
- Pause signal: Claims of broad intelligence gains from a single device or supplement.
- Pause signal: Using subjective alertness as proof of durable cognitive enhancement.
Clinician gate
Use clinician review for persistent symptoms, medication changes, abnormal results, pregnancy, or a diagnosed medical condition.
Glossary connections
Controversies to monitor
Controversies
- Subjective alertness being marketed as durable enhancement.
- Commercial scores that are not independently validated.
Core reference classes
Research classes
- Neurofeedback and attention-training trials
- Sleep, exercise, and cognition intervention literature
Evidence timeline
Linked records are ordered by publication year. A newer record is not automatically stronger; design, population, and endpoint still determine weight.
Effects of Regular Exercise on Peripheral BDNF
PubMed - Meta-analysis with meta-regression
A 2026 meta-analysis examines how regular exercise changes peripheral BDNF, while peripheral biomarker shifts remain an imperfect proxy for durable human learning or brain-specific change.
View source recordNeurofeedback Regulation and Process Evaluation in PTSD Research
Brain Connectivity / PubMed - Systematic review and statistical analysis
A 2026 review identifies methodological and process-evaluation weaknesses in PTSD neurofeedback research, reinforcing the need for protocol standardization and adverse-event reporting.
View source recordWearable Sleep and Heart-Rate Variability for MCI Detection
Yonsei Medical Journal / PubMed - Observational modeling study
A study using approximately 70 days of smart-ring data from 162 participants found that variability-focused sleep and heart-rate features improved model discrimination for mild cognitive impairment; this is a research signal, not a home diagnostic.
View source recordHome Transcranial Photobiomodulation for Mild Cognitive Impairment
Journal of Alzheimer's Disease / PubMed - Randomized double-blind placebo-controlled clinical trial
A confirmatory randomized trial evaluated home-administered transcranial photobiomodulation in 80 people with mild cognitive impairment due to Alzheimer's disease; any translation remains diagnosis-, device-, dose-, and follow-up-specific.
View source recordOnline-Guided Physical Activity, Cognition, Brain Connectivity, and the Gut Microbiome
GeroScience / PubMed - Randomized controlled trial
A randomized trial in healthy older adults evaluated an online-guided physical-activity intervention alongside cognition, resting-state brain connectivity, and gut-microbiome outcomes; the multimodal design is informative but does not isolate a single mechanism or establish a universal digital exercise protocol.
View source recordVirtual-Reality Cognitive Remediation for Mood and Psychosis Spectrum Disorders
The Lancet Digital Health / PubMed - Single-centre double-blind randomized controlled trial
A randomized trial compared immersive virtual-reality cognitive remediation with a virtual-reality control in people with mood or psychosis spectrum disorders, testing cognition and functioning after an intensive defined program; the diagnosis, content, comparator, and follow-up constrain generalization.
View source recordHome-Based Transcranial Photobiomodulation for Mild Cognitive Impairment Due to Alzheimer Disease
International Journal of Geriatric Psychiatry / PubMed - Randomized double-blind placebo-controlled confirmatory trial
A 2026 confirmatory trial evaluated home-based transcranial photobiomodulation in people with mild cognitive impairment due to Alzheimer disease, highlighting the importance of device, diagnosis, sham, dosing, and follow-up when interpreting home-use claims.
View source recordEffects of Psychedelic Microdosing on Cognitive Functions
Neuroscience and Biobehavioral Reviews / PubMed - Preregistered systematic review and meta-analysis
A preregistered meta-analysis of controlled psychedelic microdosing studies found heterogeneous results, no general cognitive-enhancement effect, and a signal for reduced cognitive control that requires better standardized and expectancy-controlled research.
View source recordEffects of Different Methods of Cannabis Use on Cognition and Blood THC: A Systematic Review
Progress in Neuro-Psychopharmacology & Biological Psychiatry / PubMed - Systematic review
A 2025 review examines how route and method of cannabis use relate to blood THC and cognitive effects, reinforcing that exposure, timing, formulation, and impairment cannot be inferred from a generic cannabis label.
View source recordThe Effects of Cannabis Use Disorder on Cognitive Functions: A Meta-Analysis
Addictive Behaviors / PubMed - Meta-analysis
A 2025 meta-analysis examines cognitive domains in people with cannabis use disorder, highlighting the need to separate acute effects, residual effects, disorder severity, age, and recovery from broad enhancement narratives.
View source recordResistance Training Volume in Older Adults
Sports Medicine / PubMed - Systematic review and network meta-analysis
A network meta-analysis of 151 randomized trials compares resistance-training volumes for physical function, lean body mass, hypertrophy, and strength in older adults.
View source recordCognitive, Sleep, and Mood Changes in the Menopausal Transition
Obstetrics & Gynecology / PubMed - Clinical review
A clinical review frames brain fog, mood, and sleep changes during menopause as common but clinically heterogeneous symptoms requiring evidence-based assessment and support.
View source recordDifferential Associations of Dopamine and Serotonin With Reward and Punishment Processes in Humans
JAMA Psychiatry / PubMed - Systematic review and meta-analysis
A 2025 synthesis separates dopamine and serotonin associations with reward and punishment processes, supporting a distributed model rather than a single chemical explanation of motivation.
View source recordTimescales of Dopamine Release in the Striatum
Current Opinion in Behavioral Sciences / PubMed - Review
A review of dopamine release across timescales shows why a single ‘dopamine level’ is an inadequate proxy for reward learning, movement, vigor, or subjective pleasure.
View source recordMind-Body Exercise, Cognitive Function, and Neuroplasticity in Mild Cognitive Impairment
Frontiers in Aging Neuroscience / PubMed - Systematic review and meta-analysis
A 2025 synthesis reports cognitive and neuroplasticity-related outcomes from mind-body exercise in older adults with mild cognitive impairment, with heterogeneity across interventions and measures.
View source recordEffectiveness of Exercise for Cognition, Memory, and Executive Function
British Journal of Sports Medicine / PubMed - Systematic umbrella review and meta-meta-analysis
An umbrella review finds exercise is associated with cognitive benefits across populations, while effect sizes, adherence, baseline health, and the type of cognitive outcome still matter.
View source recordBrain-Inspired Multisensory Learning and Neuroplasticity
Biomimetics / PubMed - Systematic review
A review connects multisensory learning principles with neuroplasticity and brain-inspired design, but engineered learning systems should not be treated as validated human cognitive enhancers by default.
View source recordMultivitamin and Mineral Use: A Rapid Review of Meta-Analyses on Health Outcomes
Ageing Research Reviews / PubMed - Rapid review of meta-analyses
A 2025 rapid review found outcome-specific signals for multivitamin and mineral use, including selected cognition and blood-pressure findings, but no established all-cause mortality or universal longevity benefit.
View source recordEfficacy of B Vitamin Supplementation on Global Cognitive Function in Older Adults
Nutrition Reviews / PubMed - Systematic review and meta-analysis of randomized trials
A 2025 meta-analysis of B6, B9, and B12 trials in older adults found a very small cognitive benefit after accounting for outliers, with the broader supplement claim still dependent on population and deficiency context.
View source recordPortable EEG Neurofeedback for ADHD
Applied Neuropsychology: Child / PubMed - Meta-analysis of randomized trials
A meta-analysis of randomized trials evaluates portable EEG neurofeedback for ADHD, providing a clinical context for interpreting consumer neurofeedback claims.
View source recordSmartphone Assessment and AI-Generated Personalized Exercise
Journal of Medical Internet Research / PubMed - Randomized controlled trial
A randomized trial in healthy older adults tested smartphone motor assessment with machine-learning-tailored exercise and reported improvements in selected balance, flexibility, and strength outcomes over eight weeks.
View source recordIntermittent Normobaric Hypoxia and Executive Function in Healthy Young Adults
Frontiers in Psychology / PubMed - Randomized controlled human trial
A randomized study evaluated a session of intermittent normobaric hypoxia in healthy young adults using multiple executive-function tests, illustrating both the value of controlled human physiology research and the limits of small, acute exposure studies.
View source recordLow-Intensity Transcranial Focused Ultrasound Amygdala Neuromodulation
PubMed / Target-engagement and clinical feasibility study - Double-blind sham-controlled target-engagement study with single-arm treatment phase
An MRI-guided low-intensity focused-ultrasound study examined amygdala target engagement and short clinical feasibility in mood, anxiety, and trauma-related disorders, motivating but not replacing larger randomized efficacy trials.
View source recordEfficacy and Safety of Esketamine for Treatment-Resistant Depression: Individual Patient Data Meta-Analysis
BMC Medicine / PubMed - Registered systematic review and individual-patient-data meta-analysis
An individual-patient-data reanalysis of randomized trials found a statistically significant but modest average benefit for esketamine plus an antidepressant at four weeks, with increased sedation, dissociation, and adverse events and uncertainty about clinical magnitude.
View source recordCreatine Supplementation and Cognitive Function in Adults
Frontiers in Nutrition / PubMed - Systematic review and meta-analysis of randomized trials
A systematic review and meta-analysis of randomized trials found domain-specific signals for memory, attention time, and processing speed, while overall cognition and executive-function findings remained less certain and population effects varied.
View source recordSuvorexant Acutely Decreases Tau Phosphorylation and Aβ in the Human CNS
Annals of Neurology - Randomized controlled mechanistic trial
An acute experiment measured cerebrospinal-fluid biomarkers after suvorexant; it did not test dementia incidence.
View source recordPlant-Derived Nootropics and Human Cognition
Critical Reviews in Food Science and Nutrition / PubMed - Systematic review
A systematic review mapped human evidence for plant-derived nootropics and described both reported cognitive signals and substantial inconsistency, supporting a substance-specific rather than category-wide interpretation.
View source recordEffects of transdermal nicotine delivery on cognitive outcomes: A meta-analysis
Acta Neurologica Scandinavica - Systematic review and meta-analysis
A patch-specific meta-analysis found a small attention benefit in healthy nonsmokers; the memory estimate was statistically inconclusive.
View source recordCognitive performance effects of nicotine and industry affiliation: a systematic review
Substance Abuse: Research and Treatment - Systematic review
This review of 32 randomized trials found inconsistent cognitive effects. It found no association between reported outcomes and industry funding, while noting incomplete disclosure and funding data.
View source recordMarijuana Research Report: What Do We Know About Marijuana?
National Institute on Drug Abuse - Federal research report
NIDA summarizes known and unresolved questions about cannabis, including effects, dependence, cognition, health risks, medical use, and the limits of current evidence.
View source recordTopic assessment
These questions test evidence interpretation and safety boundaries, not personal medical decisions.
1. What is the most defensible first question when evaluating Cognition and Performance Systems?
Show answer and explanation
What outcome, evidence, and risk boundary are defined?
A clear outcome, evidence design, and risk boundary keep an encyclopedia claim from becoming an unsafe recommendation.
2. What would make a claim about Cognition and Performance Systems more trustworthy?
Show answer and explanation
Replication with appropriate controls, context, and meaningful outcomes
Reproducibility and patient-important outcomes matter more than novelty, complexity, or an isolated signal.
Editorial update history
This log records what changed in the encyclopedia record and why the update matters for interpretation.
Added insomnia pharmacology, attributed guideline recommendations, clinical and biomarker trial snapshots, and a medication discussion guide.
Related record update: Suvorexant Acutely Decreases Tau Phosphorylation and Aβ in the Human CNS
Added study snapshots and a newer cessation review, included positive cognition evidence, clarified the industry-funding finding, and corrected journal metadata. Older review records remain available as historical versions.
Related record update: Effects of transdermal nicotine delivery on cognitive outcomes: A meta-analysis; Cognitive performance effects of nicotine and industry affiliation: a systematic review
Added a nicotine dossier separating cessation, harm reduction, dual use, and enhancement; linked dependence, withdrawal cognition, cardiovascular and aerosol exposure, product quality, and evidence-based quit support.
Related record update: Cognitive performance effects of nicotine and industry affiliation: a systematic review
Added a cannabinoid dossier connecting THC, CBD, prescription medicines, chronic-pain evidence, anxiety research, cognitive and impairment effects, dependence, product quality, interactions, and regulatory boundaries.
Related record update: Effects of Different Methods of Cannabis Use on Cognition and Blood THC: A Systematic Review; The Effects of Cannabis Use Disorder on Cognitive Functions: A Meta-Analysis; Marijuana Research Report: What Do We Know About Marijuana?
A-Z topic scaffolding, safety framing, learning paths, and linked evidence architecture established for the living encyclopedia.
Added current records spanning real-world digital cohorts, multi-omics, serum proteomics, sweat biosensing, peptides, aging clocks, kinase signaling, endocrine research, personalized nutrition, microbiome response, neurotechnology, and caloric restriction.
Related record update: Home Transcranial Photobiomodulation for Mild Cognitive Impairment
Added recent human records on microbiome-based insomnia treatment, online-guided activity and cognition, technology-assisted behavior change, and next-generation epigenetic aging clocks, with explicit translation and conflict boundaries.
Related record update: Online-Guided Physical Activity, Cognition, Brain Connectivity, and the Gut Microbiome
Added explicit dossiers for bioelectronic medicine, cellular reprogramming, microbiome engineering, organoid modeling, AI-assisted protein design, regenerative medicine, sensory substitution, and virtual-reality therapeutics, then linked current reviews, clinical studies, translational models, and early human neurotechnology evidence with explicit safety boundaries.
Related record update: Virtual-Reality Cognitive Remediation for Mood and Psychosis Spectrum Disorders
Added encyclopedia coverage for breathwork, creatine cognition, intermittent hypoxia, ketogenic metabolism, mindfulness and interoception, nootropics, photobiomodulation, and psychedelic-assisted therapy, with topic-specific safety framing and current evidence links.
Related record update: Creatine Supplementation and Cognitive Function in Adults; Intermittent Normobaric Hypoxia and Executive Function in Healthy Young Adults; Plant-Derived Nootropics and Human Cognition; Home-Based Transcranial Photobiomodulation for Mild Cognitive Impairment Due to Alzheimer Disease
Added distinct dossiers for continuous glucose monitoring, GLP-1 and incretin therapeutics, metformin geroscience, rapamycin and mTOR, transcranial focused ultrasound, polygenic risk scores, digital phenotyping, and psychedelic microdosing, with evidence lanes and explicit medical and governance boundaries.
Related record update: Low-Intensity Transcranial Focused Ultrasound Amygdala Neuromodulation; Effects of Psychedelic Microdosing on Cognitive Functions
Added dossiers for ketamine and esketamine, sleep apnea, cuffless blood pressure, extracellular vesicles, exercise mimetics, postbiotics, nutritional psychiatry, and plasma-exchange rejuvenation claims, with clinical boundaries, community-risk framing, and current research links.
Related record update: Efficacy and Safety of Esketamine for Treatment-Resistant Depression: Individual Patient Data Meta-Analysis
Added hyperbaric oxygen, wearable drug sensing, and menopause cognition and sleep coverage, connecting clinical indications to device safety, individualized treatment, symptom outcomes, and boundaries around anti-aging or enhancement claims.
Related record update: Cognitive, Sleep, and Mood Changes in the Menopausal Transition
Added distinct coverage for cardiorespiratory fitness, resistance training, protein and muscle protein synthesis, and sauna or passive heat, separating durable outcomes from wearable scores, acute biomarkers, and extreme protocols.
Related record update: Resistance Training Volume in Older Adults
Added evidence-aware dossiers for dopamine and reward learning, neuroplasticity and cognition, allostatic load and chronic stress, and slow breathing with HRV biofeedback, separating mechanisms, subjective effects, functional outcomes, and safety boundaries.
Related record update: Differential Associations of Dopamine and Serotonin With Reward and Punishment Processes in Humans; Timescales of Dopamine Release in the Striatum; Mind-Body Exercise, Cognitive Function, and Neuroplasticity in Mild Cognitive Impairment; Effects of Regular Exercise on Peripheral BDNF; Effectiveness of Exercise for Cognition, Memory, and Executive Function; Brain-Inspired Multisensory Learning and Neuroplasticity
Added dedicated dossiers for vitamin and micronutrient repletion, peptide therapeutics and research-grade compounds, off-label medication repurposing, and compounded or online-sourced medications, with current nutrition evidence, human peptide pharmacology, FDA labeling resources, and product-quality boundaries.
Related record update: Multivitamin and Mineral Use: A Rapid Review of Meta-Analyses on Health Outcomes; Efficacy of B Vitamin Supplementation on Global Cognitive Function in Older Adults
Linked evidence records
Suvorexant Acutely Decreases Tau Phosphorylation and Aβ in the Human CNS
Annals of Neurology • Randomized controlled mechanistic trial • Published: 2023-07 • Checked: Sep 14, 2026
An acute experiment measured cerebrospinal-fluid biomarkers after suvorexant; it did not test dementia incidence.
How to interpret this record
Study at a glance
- Who was studied
- 38 cognitively unimpaired adults aged 45–65 completed the experiment.
- What was compared
- Placebo and two suvorexant groups; serial sampling over 36 hours.
- What was measured
- Cerebrospinal-fluid amyloid-beta and site-specific tau phosphorylation.
- Reported result
- Selected biomarker reductions occurred; tau phosphorylation at S202 and T217 did not decrease.
- How to read the numbers
- A short mechanistic signal supporting further research.
- Where this result stops
- No evidence here of reduced dementia incidence, preserved cognition over years, or a preventive schedule. Investigator conflicts are disclosed.
- Source and version
- PubMed abstract and figure descriptions, PMID 36897120; checked September 14, 2026.
What it supports
Human biomarker changes after brief exposure.
Major limitations
Small study, short duration, selective responses, and disclosed conflicts.
What it does not establish
A biomarker change is not an established Alzheimer’s prevention benefit.
Effects of transdermal nicotine delivery on cognitive outcomes: A meta-analysis
Acta Neurologica Scandinavica • Systematic review and meta-analysis • Published: 2021-08 • Checked: Sep 14, 2026
A patch-specific meta-analysis found a small attention benefit in healthy nonsmokers; the memory estimate was statistically inconclusive.
How to interpret this record
Study at a glance
- Who was studied
- Healthy nonsmoking adults; 31 publications, 978 participants overall.
- What was compared
- Nicotine patches versus placebo patches.
- What was measured
- Cognitive-task performance, including attention and memory.
- Reported result
- Attention: standardized mean difference 0.231 (95% CI 0.106–0.356). Memory: 0.270 (95% CI −0.293–0.833), not statistically significant.
- How to read the numbers
- A small average attention effect; standardized mean difference is measured in standard deviations, not percent improvement.
- Where this result stops
- Laboratory performance does not establish sustained productivity, a favorable long-term benefit-risk balance, or equivalence to pouches and vapes.
- Source and version
- PubMed abstract, DOI 10.1111/ane.13436; checked September 14, 2026.
What it supports
The attention finding cannot be dismissed solely as relief of smoking withdrawal.
Major limitations
Route, tasks, and population constrain generalization; memory results were heterogeneous.
What it does not establish
The analysis does not establish a consumer enhancement protocol.
Cognitive performance effects of nicotine and industry affiliation: a systematic review
Substance Abuse: Research and Treatment • Systematic review • Published: 2020 • Checked: Sep 14, 2026
This review of 32 randomized trials found inconsistent cognitive effects. It found no association between reported outcomes and industry funding, while noting incomplete disclosure and funding data.
How to interpret this record
What it supports
Cognitive results varied across trials. No statistical association with industry funding was detected; incomplete disclosure limits that analysis.
Major limitations
Laboratory tasks and selected adult samples do not predict long-term functioning, dependence risk, sleep effects, or real-world productivity.
What it does not establish
Acute changes in attention, alertness, or reaction time do not establish durable cognitive enhancement or a favorable benefit-risk ratio for healthy non-users.
Effects of Different Methods of Cannabis Use on Cognition and Blood THC: A Systematic Review
Progress in Neuro-Psychopharmacology & Biological Psychiatry / PubMed • Systematic review • Published: 2025 • Checked: Aug 17, 2026
A 2025 review examines how route and method of cannabis use relate to blood THC and cognitive effects, reinforcing that exposure, timing, formulation, and impairment cannot be inferred from a generic cannabis label.
How to interpret this record
What it supports
Route and method of cannabis use influence exposure and cognitive effects, supporting a formulation- and timing-specific interpretation.
Major limitations
Acute cognition, residual effects, tolerance, dose, age, co-use, and individual susceptibility complicate translation across products and users.
What it does not establish
A subjective focus or relaxation response does not establish cognitive enhancement, safe driving, or a consistent benefit across routes.
The Effects of Cannabis Use Disorder on Cognitive Functions: A Meta-Analysis
Addictive Behaviors / PubMed • Meta-analysis • Published: 2025 • Checked: Aug 17, 2026
A 2025 meta-analysis examines cognitive domains in people with cannabis use disorder, highlighting the need to separate acute effects, residual effects, disorder severity, age, and recovery from broad enhancement narratives.
How to interpret this record
What it supports
Cannabis use disorder is associated with domain-specific cognitive questions that deserve separation from casual-use anecdotes and enhancement claims.
Major limitations
Associations are affected by age, comorbidities, use history, abstinence, testing, and study design; the review does not determine a single causal pathway for every user.
What it does not establish
Cannabis is not established as a cognitive enhancer, and a temporary subjective effect does not rule out dependence, impairment, or residual cognitive risk.
Marijuana Research Report: What Do We Know About Marijuana?
National Institute on Drug Abuse • Federal research report • Published: 2020 • Checked: Aug 17, 2026
NIDA summarizes known and unresolved questions about cannabis, including effects, dependence, cognition, health risks, medical use, and the limits of current evidence.
How to interpret this record
What it supports
NIDA summarizes established concerns and open research questions across cannabis effects, dependence, cognition, medical use, and vulnerable populations.
Major limitations
A public-health overview is not a product-specific clinical trial or individualized risk calculation, and laws and product markets vary by jurisdiction.
What it does not establish
The existence of medical or research use does not establish that any retail cannabis or CBD product is safe, standardized, or appropriate for self-treatment.
Resistance Training Volume in Older Adults
Sports Medicine / PubMed • Systematic review and network meta-analysis • Published: 2025 • Checked: Aug 17, 2026
A network meta-analysis of 151 randomized trials compares resistance-training volumes for physical function, lean body mass, hypertrophy, and strength in older adults.
How to interpret this record
What it supports
Resistance training across studied volumes improves selected physical-function, lean-mass, hypertrophy, and strength outcomes in older adults.
Major limitations
The most useful volume depends on the endpoint, health status, program duration, and participant capacity; evidence is more limited in physically impaired groups.
What it does not establish
The network ranking does not identify one universally optimal program or justify copying a high-volume protocol.
Cognitive, Sleep, and Mood Changes in the Menopausal Transition
Obstetrics & Gynecology / PubMed • Clinical review • Published: 2025 • Checked: Aug 17, 2026
A clinical review frames brain fog, mood, and sleep changes during menopause as common but clinically heterogeneous symptoms requiring evidence-based assessment and support.
How to interpret this record
What it supports
Cognition, mood, sleep, and vasomotor symptoms are clinically relevant during the menopausal transition and have multiple possible treatment pathways.
Major limitations
This is a clinical review rather than a universal treatment trial; symptoms, populations, and treatment responses are heterogeneous.
What it does not establish
Menopause-related brain fog or symptom relief does not establish dementia prevention, generalized cognitive enhancement, or one hormone protocol for everyone.
Differential Associations of Dopamine and Serotonin With Reward and Punishment Processes in Humans
JAMA Psychiatry / PubMed • Systematic review and meta-analysis • Published: 2025 • Checked: Aug 17, 2026
A 2025 synthesis separates dopamine and serotonin associations with reward and punishment processes, supporting a distributed model rather than a single chemical explanation of motivation.
How to interpret this record
What it supports
Human studies support separable associations between dopamine, serotonin, reward, and punishment processes rather than one undifferentiated reward chemical.
Major limitations
The evidence combines different tasks, manipulations, samples, and measurement methods; associations do not directly quantify a person's dopamine or motivation.
What it does not establish
This does not validate dopamine-detox programs, diagnose a neurotransmitter deficiency, or show that supplements can selectively optimize motivation.
Timescales of Dopamine Release in the Striatum
Current Opinion in Behavioral Sciences / PubMed • Review • Published: 2025 • Checked: Aug 17, 2026
A review of dopamine release across timescales shows why a single ‘dopamine level’ is an inadequate proxy for reward learning, movement, vigor, or subjective pleasure.
How to interpret this record
What it supports
Dopamine release operates across multiple temporal scales and supports different functions in striatal circuits.
Major limitations
Mechanistic reviews synthesize heterogeneous animal and human methods, and the relationship between signal dynamics and subjective experience is indirect.
What it does not establish
There is no single meaningful ‘baseline dopamine’ number that can be inferred from mood, cravings, productivity, or a consumer test.
Mind-Body Exercise, Cognitive Function, and Neuroplasticity in Mild Cognitive Impairment
Frontiers in Aging Neuroscience / PubMed • Systematic review and meta-analysis • Published: 2025 • Checked: Aug 17, 2026
A 2025 synthesis reports cognitive and neuroplasticity-related outcomes from mind-body exercise in older adults with mild cognitive impairment, with heterogeneity across interventions and measures.
How to interpret this record
What it supports
Mind-body exercise is associated with selected cognitive and neuroplasticity-related outcomes in adults with mild cognitive impairment.
Major limitations
Interventions, samples, neuroplasticity measures, and follow-up vary, and biomarker or task changes may not translate to durable everyday function.
What it does not establish
The findings do not establish dementia prevention, broad intelligence enhancement, or one universal mind-body protocol.
Effects of Regular Exercise on Peripheral BDNF
PubMed • Meta-analysis with meta-regression • Published: 2026 • Checked: Aug 17, 2026
A 2026 meta-analysis examines how regular exercise changes peripheral BDNF, while peripheral biomarker shifts remain an imperfect proxy for durable human learning or brain-specific change.
How to interpret this record
What it supports
Regular exercise can change peripheral BDNF in the studied populations and protocols.
Major limitations
Peripheral BDNF is affected by timing, assay, exercise mode, and other factors and is not a direct measure of brain-specific plasticity.
What it does not establish
Raising a blood biomarker does not prove a particular cognitive gain, permanent rewiring, or a need for BDNF-targeting supplements.
Effectiveness of Exercise for Cognition, Memory, and Executive Function
British Journal of Sports Medicine / PubMed • Systematic umbrella review and meta-meta-analysis • Published: 2025 • Checked: Aug 17, 2026
An umbrella review finds exercise is associated with cognitive benefits across populations, while effect sizes, adherence, baseline health, and the type of cognitive outcome still matter.
How to interpret this record
What it supports
Across reviews, exercise shows a beneficial signal for several cognitive outcomes, including memory and executive function.
Major limitations
Effects differ by population, outcome, dose, adherence, comparator, and study quality; average effects are not personalized prescriptions.
What it does not establish
An exercise meta-analysis does not prove that every form, intensity, or schedule will improve intelligence or prevent neurological disease.
Brain-Inspired Multisensory Learning and Neuroplasticity
Biomimetics / PubMed • Systematic review • Published: 2025 • Checked: Aug 17, 2026
A review connects multisensory learning principles with neuroplasticity and brain-inspired design, but engineered learning systems should not be treated as validated human cognitive enhancers by default.
How to interpret this record
What it supports
Multisensory learning and neuroplasticity are relevant design principles for learning systems and rehabilitation research.
Major limitations
Brain-inspired engineering concepts and human intervention evidence are not interchangeable, and transfer beyond trained tasks requires direct testing.
What it does not establish
A multisensory app, brain scan, or learning device is not automatically a validated cognitive enhancer.
Multivitamin and Mineral Use: A Rapid Review of Meta-Analyses on Health Outcomes
Ageing Research Reviews / PubMed • Rapid review of meta-analyses • Published: 2025 • Checked: Aug 17, 2026
A 2025 rapid review found outcome-specific signals for multivitamin and mineral use, including selected cognition and blood-pressure findings, but no established all-cause mortality or universal longevity benefit.
How to interpret this record
What it supports
Multivitamin and mineral interventions show outcome-specific signals in selected populations, including some cognition and blood-pressure outcomes.
Major limitations
The review combines different formulations, populations, doses, durations, and endpoints; pooled signals do not establish a universal healthspan or longevity effect.
What it does not establish
Taking a multivitamin does not prove longer life, broad disease prevention, or a need for high-dose stacking when nutritional adequacy is already present.
Efficacy of B Vitamin Supplementation on Global Cognitive Function in Older Adults
Nutrition Reviews / PubMed • Systematic review and meta-analysis of randomized trials • Published: 2025 • Checked: Aug 17, 2026
A 2025 meta-analysis of B6, B9, and B12 trials in older adults found a very small cognitive benefit after accounting for outliers, with the broader supplement claim still dependent on population and deficiency context.
How to interpret this record
What it supports
B-vitamin supplementation may produce a very small cognitive benefit in older adults in randomized evidence after accounting for influential studies.
Major limitations
The effect is population- and context-dependent, and heterogeneity, baseline status, diet, and outcome choice affect interpretation.
What it does not establish
B vitamins are not established as a general nootropic for people without deficiency or a substitute for evaluating cognitive symptoms.
Portable EEG Neurofeedback for ADHD
Applied Neuropsychology: Child / PubMed • Meta-analysis of randomized trials • Published: 2025 • Checked: Aug 17, 2026
A meta-analysis of randomized trials evaluates portable EEG neurofeedback for ADHD, providing a clinical context for interpreting consumer neurofeedback claims.
How to interpret this record
What it supports
Portable EEG neurofeedback has been evaluated in randomized trials for a defined clinical population.
Major limitations
Clinical indication, protocol fidelity, comparator quality, and transfer to untrained tasks remain important constraints.
What it does not establish
Results in ADHD treatment studies do not establish broad cognitive enhancement in healthy users.
Neurofeedback Regulation and Process Evaluation in PTSD Research
Brain Connectivity / PubMed • Systematic review and statistical analysis • Published: 2026 • Checked: Aug 17, 2026
A 2026 review identifies methodological and process-evaluation weaknesses in PTSD neurofeedback research, reinforcing the need for protocol standardization and adverse-event reporting.
How to interpret this record
What it supports
Protocol regulation, process evaluation, and adverse-event reporting are central weaknesses to address in neurofeedback research.
Major limitations
Small samples and heterogeneous training methods make cross-study comparisons difficult.
What it does not establish
A positive subjective response does not establish a durable neural or clinical effect.
Wearable Sleep and Heart-Rate Variability for MCI Detection
Yonsei Medical Journal / PubMed • Observational modeling study • Published: 2026 • Checked: Aug 17, 2026
A study using approximately 70 days of smart-ring data from 162 participants found that variability-focused sleep and heart-rate features improved model discrimination for mild cognitive impairment; this is a research signal, not a home diagnostic.
How to interpret this record
What it supports
Longitudinal variability features from wearable sleep and heart-rate data may improve research models for distinguishing mild cognitive impairment.
Major limitations
The work is observational and model-dependent; performance in new devices, populations, and clinical workflows requires external validation.
What it does not establish
A consumer wearable score is not a diagnosis and should not replace cognitive or medical evaluation.
Smartphone Assessment and AI-Generated Personalized Exercise
Journal of Medical Internet Research / PubMed • Randomized controlled trial • Published: 2025 • Checked: Aug 17, 2026
A randomized trial in healthy older adults tested smartphone motor assessment with machine-learning-tailored exercise and reported improvements in selected balance, flexibility, and strength outcomes over eight weeks.
How to interpret this record
What it supports
Smartphone motor assessment paired with tailored exercise improved selected functional outcomes in the studied healthy older adults.
Major limitations
Results were population-, program-, and outcome-specific, with a relatively short intervention and no proof that every algorithmic plan is superior.
What it does not establish
AI-generated exercise is not automatically individualized medical care or a substitute for professional evaluation when risk is present.
Home Transcranial Photobiomodulation for Mild Cognitive Impairment
Journal of Alzheimer's Disease / PubMed • Randomized double-blind placebo-controlled clinical trial • Published: 2026 • Checked: Aug 17, 2026
A confirmatory randomized trial evaluated home-administered transcranial photobiomodulation in 80 people with mild cognitive impairment due to Alzheimer's disease; any translation remains diagnosis-, device-, dose-, and follow-up-specific.
How to interpret this record
What it supports
A randomized clinical trial provides indication-specific evidence to evaluate home transcranial photobiomodulation for cognitive outcomes in mild cognitive impairment due to Alzheimer's disease.
Major limitations
The diagnosis, device, dose, outcome measures, and follow-up define the result; it does not establish effects in healthy adults or across unrelated conditions.
What it does not establish
The study does not authorize unsupervised brain stimulation, generalized cognitive enhancement claims, or substituting a device for clinical evaluation.
Online-Guided Physical Activity, Cognition, Brain Connectivity, and the Gut Microbiome
GeroScience / PubMed • Randomized controlled trial • Published: 2026 • Checked: Aug 17, 2026
A randomized trial in healthy older adults evaluated an online-guided physical-activity intervention alongside cognition, resting-state brain connectivity, and gut-microbiome outcomes; the multimodal design is informative but does not isolate a single mechanism or establish a universal digital exercise protocol.
How to interpret this record
What it supports
A randomized trial can test whether structured online-guided activity is associated with changes in cognition and multimodal brain or microbiome measures in a defined older population.
Major limitations
The intervention is multimodal, outcomes may be population-specific, and parallel changes cannot identify a single causal mechanism or guarantee transfer to other groups.
What it does not establish
A multimodal activity trial does not prove that a consumer app, microbiome shift, or connectivity measure independently improves cognition.
Virtual-Reality Cognitive Remediation for Mood and Psychosis Spectrum Disorders
The Lancet Digital Health / PubMed • Single-centre double-blind randomized controlled trial • Published: 2026 • Checked: Aug 17, 2026
A randomized trial compared immersive virtual-reality cognitive remediation with a virtual-reality control in people with mood or psychosis spectrum disorders, testing cognition and functioning after an intensive defined program; the diagnosis, content, comparator, and follow-up constrain generalization.
How to interpret this record
What it supports
A defined randomized trial provides indication-specific evidence for an immersive virtual-reality cognitive-remediation program with an active virtual-reality control.
Major limitations
Diagnosis, intervention intensity and content, comparator, follow-up, transfer to daily function, and setting constrain generalization beyond the studied population and program.
What it does not establish
The trial does not establish universal cognitive enhancement or replacement for assessment and treatment of psychiatric conditions.
Creatine Supplementation and Cognitive Function in Adults
Frontiers in Nutrition / PubMed • Systematic review and meta-analysis of randomized trials • Published: 2024 • Checked: Aug 17, 2026
A systematic review and meta-analysis of randomized trials found domain-specific signals for memory, attention time, and processing speed, while overall cognition and executive-function findings remained less certain and population effects varied.
How to interpret this record
What it supports
A randomized-trial synthesis supports domain-specific investigation of creatine for memory, attention, and processing outcomes.
Major limitations
The included populations, cognitive tasks, durations, dietary context, and certainty vary; overall cognition and executive-function results are less settled.
What it does not establish
The evidence does not establish creatine as a universal nootropic, intelligence enhancer, or substitute for sleep and clinical care.
Intermittent Normobaric Hypoxia and Executive Function in Healthy Young Adults
Frontiers in Psychology / PubMed • Randomized controlled human trial • Published: 2025 • Checked: Aug 17, 2026
A randomized study evaluated a session of intermittent normobaric hypoxia in healthy young adults using multiple executive-function tests, illustrating both the value of controlled human physiology research and the limits of small, acute exposure studies.
How to interpret this record
What it supports
A small randomized human study tests an acute intermittent normobaric hypoxia exposure with multiple executive-function measures.
Major limitations
The sample is small, exposure is acute, and healthy-young-adult results do not establish a training dose, long-term adaptation, or safety in people with disease.
What it does not establish
The study does not authorize consumer hypoxia devices, breath-hold challenges, or claims of cognitive or longevity enhancement.
Plant-Derived Nootropics and Human Cognition
Critical Reviews in Food Science and Nutrition / PubMed • Systematic review • Published: 2022 • Checked: Aug 17, 2026
A systematic review mapped human evidence for plant-derived nootropics and described both reported cognitive signals and substantial inconsistency, supporting a substance-specific rather than category-wide interpretation.
How to interpret this record
What it supports
The review identifies which plant-derived cognitive-enhancement claims have been studied and where results remain inconsistent.
Major limitations
The evidence is older, products and extracts vary, trials are heterogeneous, and review-level findings do not resolve purity, interactions, or modern gray-market formulations.
What it does not establish
A plant-derived label does not establish safety, efficacy, legality, or a reason to combine multiple nootropics.
Home-Based Transcranial Photobiomodulation for Mild Cognitive Impairment Due to Alzheimer Disease
International Journal of Geriatric Psychiatry / PubMed • Randomized double-blind placebo-controlled confirmatory trial • Published: 2026 • Checked: Aug 17, 2026
A 2026 confirmatory trial evaluated home-based transcranial photobiomodulation in people with mild cognitive impairment due to Alzheimer disease, highlighting the importance of device, diagnosis, sham, dosing, and follow-up when interpreting home-use claims.
How to interpret this record
What it supports
A confirmatory randomized trial provides indication-specific evidence about home transcranial photobiomodulation in mild cognitive impairment due to Alzheimer disease.
Major limitations
Device parameters, diagnosis, sample, sham quality, adherence, and follow-up limit transfer to consumer red-light products or other goals.
What it does not establish
The result does not establish generic red-light panels as cognitive enhancement or a substitute for dementia evaluation and treatment.
Low-Intensity Transcranial Focused Ultrasound Amygdala Neuromodulation
PubMed / Target-engagement and clinical feasibility study • Double-blind sham-controlled target-engagement study with single-arm treatment phase • Published: 2025 • Checked: Aug 17, 2026
An MRI-guided low-intensity focused-ultrasound study examined amygdala target engagement and short clinical feasibility in mood, anxiety, and trauma-related disorders, motivating but not replacing larger randomized efficacy trials.
How to interpret this record
What it supports
The study provides early human evidence about MRI-guided tFUS target engagement, feasibility, and short-term clinical signals in a defined psychiatric research population.
Major limitations
The target-engagement phase and unblinded treatment phase have different evidentiary strength, and the study requires larger randomized efficacy and safety trials.
What it does not establish
The study does not establish home ultrasound, general cognitive enhancement, or safe neuromodulation outside qualified clinical research.
Effects of Psychedelic Microdosing on Cognitive Functions
Neuroscience and Biobehavioral Reviews / PubMed • Preregistered systematic review and meta-analysis • Published: 2026 • Checked: Aug 17, 2026
A preregistered meta-analysis of controlled psychedelic microdosing studies found heterogeneous results, no general cognitive-enhancement effect, and a signal for reduced cognitive control that requires better standardized and expectancy-controlled research.
How to interpret this record
What it supports
The meta-analysis synthesizes controlled microdosing studies and tests whether cognitive effects generalize across domains, substances, doses, and timing.
Major limitations
The evidence is heterogeneous, samples are limited, blinding is difficult, and acute effects may not represent durable change or clinical benefit.
What it does not establish
The analysis does not establish microdosing as cognitive enhancement, depression treatment, or safe unsupervised practice.
Efficacy and Safety of Esketamine for Treatment-Resistant Depression: Individual Patient Data Meta-Analysis
BMC Medicine / PubMed • Registered systematic review and individual-patient-data meta-analysis • Published: 2025 • Checked: Aug 17, 2026
An individual-patient-data reanalysis of randomized trials found a statistically significant but modest average benefit for esketamine plus an antidepressant at four weeks, with increased sedation, dissociation, and adverse events and uncertainty about clinical magnitude.
How to interpret this record
What it supports
Individual-patient-data reanalysis provides an indication-specific estimate of esketamine efficacy, relapse, and adverse events in randomized trials for treatment-resistant depression.
Major limitations
The average benefit was modest, some analyses had unblinding or selection concerns, and the results depend on supervised formulation, co-treatment, and follow-up.
What it does not establish
The review does not establish take-home ketamine, wellness use, universal remission, or a safe self-directed schedule.